Ryvu Therapeutics' Global Licensee Menarini to Expand Development of MEN1703 (SEL24) with a New Study in Advanced Diffuse Large B-Cell Lymphoma (DLBCL)

/PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address...

Related Keywords

Poland ,Warsaw ,L67 ,Elcin Barker Ergun ,Pawel Przewiezlikowski ,Menarini Group ,Merck Kgaa ,Warsaw Stock Exchange ,Merck Kga ,Steering Committee ,Joint Steering Committee ,Ryvu Therapeutics ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Licensing ,Clinical Trials Amp Medical Discoveries ,